Edition:
United States

Sinclair Pharma PLC (SPH.L)

SPH.L on London Stock Exchange

32.88GBp
--
Change (% chg)

-- (--)
Prev Close
32.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
656,038
52-wk High
36.75
52-wk Low
26.00

Latest Key Developments (Source: Significant Developments)

Sinclair Pharma posts FY sales growth of 51 pct
Tuesday, 21 Mar 2017 03:00am EDT 

Sinclair Pharma Plc : FY sales growth of 51% at £37.8 million, (2015: £25.0 million, 18 months £45.5 million) . FY gross profit increased 56% to £26.7 million (2015: £17.1 million, 18 months £31.8 million) . FY adjusted ebitda. loss narrowed to £6.1 million (2015: £8.0 million, 18 months £15.4 million) . Trading in Q1 2017 in line with management expectations .Looking ahead, board expects Sinclair to be adjusted EBITDA positive in 2017 - CEO.  Full Article

Alliance Pharma updates on settlement agreement with Sinclair Pharma
Tuesday, 21 Mar 2017 03:00am EDT 

Alliance Pharma Plc : Settlement agreement with sinclair pharma plc . Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™ . Terms are: £4 million in cash to be paid to Coby Sinclair on or before 30 April; £1 million to be paid to co by sinclair on or before 30 June 2018 . Sinclair relinquishes any and all rights to Flammacerium™ (US) with immediate effect and transfers them to company .Cash element of compensation will be used by company to reduce its current bank loans..  Full Article

Sinclair Pharma says Christophe Foucher has stepped down from board
Thursday, 1 Sep 2016 02:00am EDT 

Sinclair Pharma Plc :Christophe foucher, chief operating officer, has stepped down from board with immediate effect.  Full Article

Sinclair Pharma says second interim period revenues of 17.2 mln stg
Tuesday, 19 Jul 2016 02:00am EDT 

Sinclair Pharma Plc : In second interim period, sinclair increased revenues to £17.2m, compared to £7.7m in first interim period .Appointment of Alan Musgrave Olby to board of Sinclair with immediate effect.  Full Article

Almirall signs US distribution deal with Sinclair Pharma
Monday, 23 May 2016 11:34am EDT 

Almirall SA : Signs through its Dallas based company Thermigen, an exclusive US strategic marketing collaboration agreement for Silhouette Instalift (TM) with Sinclair Pharma Plc .Thermigen has been initially granted with exclusive four-year distribution rights for US market until mid-2020.  Full Article

Sinclair Pharma expects to deliver 40 pct FY rev growth
Friday, 20 May 2016 02:14am EDT 

Sinclair Pharma Plc : Sinclair continues to expect to deliver 40% revenue growth in calendar 2016 .Us collaboration and positive trading update.  Full Article

More From Around the Web

BRIEF-Alliance Pharma updates on settlement agreement with Sinclair Pharma

* Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™